Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • News
  • Podcast
  • Jetstream
  • Contact
Select Page
Major US Hospitals Adopt DeepLook Medical’s AI Platform for Breast Cancer Detection

Major US Hospitals Adopt DeepLook Medical’s AI Platform for Breast Cancer Detection

by Xcellerant Ventures | May 15, 2025 | Portfolio Company News

DeepLook Medical, a women’s health technology company advancing medical imaging through AI-powered visual enhancement, has announced the commercial deployment of its flagship platform, DL Precise, at several leading healthcare institutions including Cleveland Clinic,...
DeepLook Medical Advances Commercialization of DL Precise™ Across Major Healthcare Institutions Nationwide

DeepLook Medical Advances Commercialization of DL Precise™ Across Major Healthcare Institutions Nationwide

by Xcellerant Ventures | May 15, 2025 | Portfolio Company News

Company expands national presence with DL Precise™ and launches new clinical studies Phoenix, AZ – DeepLook Medical, a company advancing medical imaging through visual enhancement technology, today announced that its flagship product, DL Precise™, is now in...
DeepLook Medical’s Imaging Software Now in Commercial Use at Major Healthcare Institutions

DeepLook Medical’s Imaging Software Now in Commercial Use at Major Healthcare Institutions

by Xcellerant Ventures | May 8, 2025 | Portfolio Company News

Company expands national presence with DL Precise and launches new clinical studies May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently announced that its flagship product, DL Precise, is now in...
CRISPR QC Sees Quality Control Need for Gene Sequencing

CRISPR QC Sees Quality Control Need for Gene Sequencing

by Xcellerant Ventures | Apr 29, 2025 | Portfolio Company News

BIOTECH: Co. Shifting to Commercialization with Recent Capital Funding SAN DIEGO – While research and development of gene editing-based therapies has exploded across the biotech industry in recent years, many companies still lack a process to prevent bad chemical...
Glaucoma Breakthrough: Timolol Microdrops Reduce Waste and Improve Patient Safety

Glaucoma Breakthrough: Timolol Microdrops Reduce Waste and Improve Patient Safety

by Xcellerant Ventures | Apr 17, 2025 | Portfolio Company News

Revolutionizing Glaucoma Treatment: Timolol Microdrops Prove Just as Effective—with Less Waste There’s exciting news in the world of eye health that could change how glaucoma is managed. A recent clinical study has found that Timolol microdrops are just as...
« Older Entries
Next Entries »

Recent Posts

  • Democratizing health care: There’s an app for that
  • Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
  • DeepLook Medical Expands Precision Imaging Capabilities Through Strategic Partnerships and Expert Advisors, Integrating Innovative Solutions into Widely Used Platforms to Deliver Critical Insights at
  • DeepLook Medical and NHS Oxford University UK announce new study
  • Scottsdale’s Xcellerant Ventures Launches Jetstream Venture Fund, Expanding Access to VC-Style Investing

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023